M V Martin

Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

F. Peter Guengerich, M V Martin, Philippe Beaune et al. · Journal of Biological Chemistry · 1986 · 730 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.

Linda M. Distlerath, P.E.B. Reilly, M V Martin et al. · Journal of Biological Chemistry · 1985 · 318 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Expression of Modified Human Cytochrome P450 1A2 in Escherichia coli: Stabilization, Purification, Spectral Characterization, and Catalytic Activities of the Enzyme

Punam Sandhu, Zhimou Guo, T. Baba et al. · Archives of Biochemistry and Biophysics · 1994 · 187 citations

Life Sciences, Biochemistry, Molecular Biology +17

Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase.

Jorge H. Capdevila, Armando Karara, David J. Waxman et al. · Journal of Biological Chemistry · 1990 · 143 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling.

T. Wolff, Linda M. Distlerath, Mark Worthington et al. · PubMed · 1985 · 125 citations

Medicine, Biochemistry, Pharmacology +17